We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£885.00
It has never been this cheap. We have no record of a lower price.
£885 today · cheaper than every other day in the last 2 months
2026-2031 World Outlook for Antifungal Azole Drugs
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 5 days · 5 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 5 days • 1 price levels
Price Analysis
Most common price: £885 (5 days, 100.0%)
Price range: £885 - £885
Price levels: 1 different prices over 5 days
Description
Key Features
Covers the 2026-2031 forecast period with projections for antifungal azole drug markets across global regions.
Published by ICON Group International, Inc., a recognised provider of market research and industry intelligence.
Analyses competitive dynamics, regulatory landscape, and technological advancements affecting azole drug development.
Identifies emerging growth opportunities and therapeutic applications for antifungal azole compounds.
Serves pharmaceutical companies, investors, healthcare analysts, and strategic planners in the global healthcare industry.
Product Specifications
- Format
- paperback
- ASIN
- B0FG2VNCCW
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 04 June 2025
- Listed Since
- 30 June 2025
Similar Products You Might Like
The 2026-2031 World Outlook for Infectious Disease Drugs
The 2026-2031 World Outlook for Anti-Malarial Drugs
The 2026-2031 World Outlook for OTC Drugs
The 2026-2031 World Outlook for Kinase Inhibitor Drugs
The 2026-2031 World Outlook for HIV Drugs
The 2026-2031 World Outlook for Pharmaceutical Excipients
The 2026-2031 World Outlook for Antithrombotic Drugs
The 2026-2031 World Outlook for Lyophilized Injectable Drugs
The 2026-2031 World Outlook for Epilepsy Drugs
The 2026-2031 World Outlook for Medication Management
The 2026-2031 World Outlook for Anticoagulant Drugs
The 2026-2031 World Outlook for Hydroxychloroquine
The 2026-2031 World Outlook for Oligonucleotide Therapeutics
The 2026-2031 World Outlook for Antibody Drug Conjugates
The 2026-2031 World Outlook for Infectious Disease Treatments
The 2026-2031 World Outlook for Kinase Inhibitors
The 2026-2031 World Outlook for Local Anesthesia Drugs
The 2026-2031 World Outlook for Injectable Diabetes Drugs
The 2026-2031 World Outlook for Complementary and Alternative Medicines
The 2026-2031 World Outlook for Vaginitis Therapeutics
The 2026-2031 World Outlook for Vaccine Adjuvants
The 2026-2031 World Outlook for Artificial Intelligence in Medicines
The 2026-2031 World Outlook for Anticoagulant Reversal Drugs